UPTRAVI Titration Pack
Selexipag · KIT · Actelion Pharmaceuticals US, Inc.
No Recall History
Plain English
UPTRAVI Titration Pack is a kit containing selexipag. Manufactured by Actelion Pharmaceuticals US, Inc..
Key Facts
- Brand Name
- UPTRAVI Titration Pack
- Generic Name
- Selexipag
- NDC Code (Product)
66215-628- Manufacturer
- Actelion Pharmaceuticals US, Inc.
- Dosage Form
- KIT
- Marketing Status
- Application #
- NDA207947
- Marketing Start
- 12/21/2015
Recall History
No Recall HistorySide Effects Reported to FDA
FDA FAERS database · These are reported events, not confirmed side effects
headache586 reports
dyspnoea466 reports
diarrhoea461 reports
nausea384 reports
fatigue259 reports
pain in jaw248 reports
vomiting238 reports
dizziness231 reports
pain228 reports
hypotension187 reports
Frequently Asked Questions
What is UPTRAVI Titration Pack used for?
UPTRAVI Titration Pack contains Selexipag. It is a kit taken as directed. Consult your doctor for specific uses.
Is UPTRAVI Titration Pack a controlled substance?
UPTRAVI Titration Pack is not classified as a controlled substance by the DEA.
What is the generic name for UPTRAVI Titration Pack?
The generic name for UPTRAVI Titration Pack is Selexipag. There are 12 other brand versions of Selexipag.
What is the NDC code for UPTRAVI Titration Pack ?
The NDC (National Drug Code) for UPTRAVI Titration Pack is 66215-628, listed by Actelion Pharmaceuticals US, Inc..